138 related articles for article (PubMed ID: 16569882)
1. In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis.
Hoeben BJ; Burgess DS; McConville JT; Najvar LK; Talbert RL; Peters JI; Wiederhold NP; Frei BL; Graybill JR; Bocanegra R; Overhoff KA; Sinswat P; Johnston KP; Williams RO
Antimicrob Agents Chemother; 2006 Apr; 50(4):1552-4. PubMed ID: 16569882
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
Alvarez CA; Wiederhold NP; McConville JT; Peters JI; Najvar LK; Graybill JR; Coalson JJ; Talbert RL; Burgess DS; Bocanegra R; Johnston KP; Williams RO
J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
Duret C; Merlos R; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
[TBL] [Abstract][Full Text] [Related]
4. [Role of chemoprophylaxis in the prevention of invasive aspergillosis].
Joly V
Pathol Biol (Paris); 1994 Sep; 42(7):694-9. PubMed ID: 7877864
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
[TBL] [Abstract][Full Text] [Related]
6. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
[No Abstract] [Full Text] [Related]
7. Cryogenic liquids, nanoparticles, and microencapsulation.
Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized antifungal prophylaxis: the winds of change?
Perfect JR
Clin Infect Dis; 2008 May; 46(9):1409-11. PubMed ID: 18419444
[No Abstract] [Full Text] [Related]
9. Itraconazole-loaded nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons.
Pardeike J; Weber S; Zarfl HP; Pagitz M; Zimmer A
Eur J Pharm Biopharm; 2016 Nov; 108():269-276. PubMed ID: 27449629
[TBL] [Abstract][Full Text] [Related]
10. Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infection.
Uchida K; Shimogawara K; Yamaguchi H
J Antimicrob Chemother; 2011 Mar; 66(3):626-34. PubMed ID: 21172782
[TBL] [Abstract][Full Text] [Related]
11. NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols.
Pornputtapitak W; El-Gendy N; Berkland C
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):341-52. PubMed ID: 25679514
[TBL] [Abstract][Full Text] [Related]
12. A model for treating avian aspergillosis: serum and lung tissue kinetics for Japanese quail (Coturnix japonica) following single and multiple aerosol exposures of a nanoparticulate itraconazole suspension.
Rundfeldt C; Wyska E; Steckel H; Witkowski A; Jeżewska-Witkowska G; Wlaź P
Med Mycol; 2013 Nov; 51(8):800-10. PubMed ID: 23815436
[TBL] [Abstract][Full Text] [Related]
13. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary aspergillosis and itraconazole].
Serrano-Heranz R; Alvarez-Sala JL
Arch Bronconeumol; 1995; 31(7):372-3. PubMed ID: 8777537
[No Abstract] [Full Text] [Related]
15. Single dose and multiple dose studies of itraconazole nanoparticles.
Vaughn JM; McConville JT; Burgess D; Peters JI; Johnston KP; Talbert RL; Williams RO
Eur J Pharm Biopharm; 2006 Jun; 63(2):95-102. PubMed ID: 16516450
[TBL] [Abstract][Full Text] [Related]
16. Intravenous itraconazole for treating invasive pulmonary aspergillosis in neutropenic patients with acute lymphoblastic leukemia.
Picardi M; Camera A; Luciano L; Ciancia R; Rotoli B
Haematologica; 2003 Feb; 88(2):ELT01. PubMed ID: 12604432
[No Abstract] [Full Text] [Related]
17. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
Yang W; Tam J; Miller DA; Zhou J; McConville JT; Johnston KP; Williams RO
Int J Pharm; 2008 Sep; 361(1-2):177-88. PubMed ID: 18556158
[TBL] [Abstract][Full Text] [Related]
18. Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model.
McConville JT; Overhoff KA; Sinswat P; Vaughn JM; Frei BL; Burgess DS; Talbert RL; Peters JI; Johnston KP; Williams RO
Pharm Res; 2006 May; 23(5):901-11. PubMed ID: 16715380
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
[TBL] [Abstract][Full Text] [Related]
20. Aerosol hamycin is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis.
Dhuley JN
Rocz Akad Med Bialymst; 2001; 46():317-25. PubMed ID: 11780575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
